1. Home
  2. NVAX vs GSAT Comparison

NVAX vs GSAT Comparison

Compare NVAX & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • GSAT
  • Stock Information
  • Founded
  • NVAX 1987
  • GSAT 2003
  • Country
  • NVAX United States
  • GSAT United States
  • Employees
  • NVAX N/A
  • GSAT N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • GSAT Telecommunications Equipment
  • Sector
  • NVAX Health Care
  • GSAT Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • GSAT Nasdaq
  • Market Cap
  • NVAX 2.0B
  • GSAT 2.8B
  • IPO Year
  • NVAX 1995
  • GSAT 2006
  • Fundamental
  • Price
  • NVAX $11.63
  • GSAT $1.25
  • Analyst Decision
  • NVAX Buy
  • GSAT
  • Analyst Count
  • NVAX 5
  • GSAT 0
  • Target Price
  • NVAX $15.80
  • GSAT N/A
  • AVG Volume (30 Days)
  • NVAX 5.1M
  • GSAT 5.4M
  • Earning Date
  • NVAX 08-08-2024
  • GSAT 10-31-2024
  • Dividend Yield
  • NVAX N/A
  • GSAT N/A
  • EPS Growth
  • NVAX N/A
  • GSAT N/A
  • EPS
  • NVAX N/A
  • GSAT N/A
  • Revenue
  • NVAX $987,667,000.00
  • GSAT $226,957,000.00
  • Revenue This Year
  • NVAX N/A
  • GSAT $10.19
  • Revenue Next Year
  • NVAX N/A
  • GSAT $6.95
  • P/E Ratio
  • NVAX N/A
  • GSAT N/A
  • Revenue Growth
  • NVAX N/A
  • GSAT 17.81
  • 52 Week Low
  • NVAX $3.53
  • GSAT $1.01
  • 52 Week High
  • NVAX $23.86
  • GSAT $2.13
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 44.54
  • GSAT 48.26
  • Support Level
  • NVAX $11.26
  • GSAT $1.21
  • Resistance Level
  • NVAX $13.84
  • GSAT $1.33
  • Average True Range (ATR)
  • NVAX 0.89
  • GSAT 0.10
  • MACD
  • NVAX 0.04
  • GSAT -0.01
  • Stochastic Oscillator
  • NVAX 22.15
  • GSAT 13.33

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: